Modeling Approaches for Determination of Pharmacokinetics/Pharmacodynamics
Explore insights from Certara experts on how PK/PD modeling streamlines biologic drug development.
CertaraAugust 5, 2025
Breaking New Ground: EMA Qualification of the Simcyp® Simulator Ushers in a New Era for PBPK Modeling
The Simcyp Simulator receives EMA qualification—the first and only PBPK platform formally qualified for any…
CertaraAugust 5, 2025
Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling
Certara announces that EMA has formally qualified the Simcyp® Simulator for use in regulatory submissions…
CertaraAugust 4, 2025
MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines
Learn how clinical pharmacologists and modeling experts collaborate to improve preclinical-to-clinical translation.
CertaraJuly 29, 2025
Boosting Confidence in Drug Discovery with PBPK
Explore Simcyp Discovery Version 2 updates to boost early-stage drug development.
CertaraJuly 25, 2025
How Pharma Can Transition to Non-animal Studies for Investigational Drugs
Pharma companies can ease the transition to non-animal studies for investigational drugs by leveraging NAMs…
CertaraJuly 25, 2025
